| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/12/2004 | CN1149081C Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
| 05/12/2004 | CN1149080C Prilocaine and hydrofluorocarbon aerosol preparations |
| 05/12/2004 | CN1149078C Treatment of chronic inflammatory disorders of gastrointestinal tract |
| 05/12/2004 | CN1149077C Rapidly disintegrable solid preparation |
| 05/12/2004 | CN1149076C Preparation of powder agglomerates |
| 05/12/2004 | CN1149075C Enteric coated pharmaceutical compsn, and method of mfg. |
| 05/12/2004 | CN1149074C Bioactive glass application for preparing medicine of treatment of inflammation in skin conditions |
| 05/12/2004 | CN1149073C Medicinal aerosol products |
| 05/12/2004 | CN1149072C New pharmaceutical composition with anaesthetic effect |
| 05/12/2004 | CN1149071C Pharmaceutical preparation with a hydrophobic active substance and an effervescent system, and process for preparing said prparation |
| 05/12/2004 | CN1149021C Liquid oral compositions comprising a calcium compound and an acidulant |
| 05/11/2004 | US6734308 Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3,- dihydroxybutanedioate salts and method of production |
| 05/11/2004 | US6734307 Use against multiply resistant gram positive pathogens; have a diazine moiety attached to the phenyloxazolidinone which is further substituted by heterocyclic, aryl, substituted aryl, heteroaroamatic ring |
| 05/11/2004 | US6734306 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 05/11/2004 | US6734302 Cis-imidazolines |
| 05/11/2004 | US6734301 2,3,4,5-Tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds |
| 05/11/2004 | US6734300 Purification using cationic ion exchange resins |
| 05/11/2004 | US6734295 Modified CRE recombinase gene for mammals |
| 05/11/2004 | US6734215 Exo-S-mecamylamine formulation and use in treatment |
| 05/11/2004 | US6734214 Treating at least one of diabetes and complications arising from diabetes in a subject by administering to the subject a therapeutically effective amount of a mixture of polylactic acids |
| 05/11/2004 | US6734213 Administering (+)-(2s,3s)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol or salts and solvates thereof to treat alcoholism |
| 05/11/2004 | US6734212 Methods and compositions for treating or preventing bacterial infection |
| 05/11/2004 | US6734211 Compositions and methods for promoting nerve regeneration |
| 05/11/2004 | US6734210 Therapeutically improved salts of azelaic acid |
| 05/11/2004 | US6734208 Adjustment transforming growth factor concentration; antiinflammatory agents |
| 05/11/2004 | US6734206 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 05/11/2004 | US6734204 Permit selective modulation of or even have opposing effects on different serotonin receptor subtypes |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734200 Antibiotic compounds containing a substituted oxazolidinone ring; activity against gram-positive pathogens |
| 05/11/2004 | US6734197 Combination therapy for type II diabetes or Syndrome X |
| 05/11/2004 | US6734196 Substituted pyridine or piperidine compounds |
| 05/11/2004 | US6734195 Stable donepezil hydrochloride amorphous tablet for the treatment of dementia or alzheimer's disease |
| 05/11/2004 | US6734194 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 05/11/2004 | US6734192 Administering quercetin or derivatives thereof, with the channel blocker and quinoline for treatment of hiv infection |
| 05/11/2004 | US6734190 Dihydrodipyrazolopyridinylbenzamide and -sulfonamide inhibitors of B7-1 |
| 05/11/2004 | US6734189 Hydroxamic and carboxylic acid derivatives |
| 05/11/2004 | US6734188 Composition for treatment of constipation and irritable bowel syndrome |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 05/11/2004 | US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 05/11/2004 | US6734181 Gastric acid secretory inhibition activity, gastric mucous membrane protection activity; treatment of ulcers and helicobacter pylori infecions |
| 05/11/2004 | US6734179 Sulfur compounds such as 4-fluoro-n-(4-methoxy-7-(tetrahydro-pyran-4-yl)-benzothiazol-2-yl) -benzamide, used as preferential adenosine receptor ligands for the prophylaxis of neurodegenerative disorders |
| 05/11/2004 | US6734178 Contacting host with a cephalotaxine and an antiproliferative agent such as an alkylating agent, an intercalating agent, a metal coordination complex, a nucleoside, a nucleic acid enyme or protein inhibitor to modulate cell proliferation |
| 05/11/2004 | US6734177 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors |
| 05/11/2004 | US6734175 Administering to an obese patient or one at risk of becoming obese a therapeutic compound that attenuates the binding of agouti-related protein to melanocortin receptors, free of binding of alpha-melanocyte stimulating hormone to receptor |
| 05/11/2004 | US6734174 Modulators of the function of receptors of the TNF/NGF receptor |
| 05/11/2004 | US6734170 Cellular uptake of bioactive agents |
| 05/11/2004 | US6734167 Uses of transport proteins |
| 05/11/2004 | US6734165 Method for re-sensitizing vancomycin resistant bacteria which selectively cleave a cell wall depsipeptide |
| 05/11/2004 | US6734161 Peptide nucleic acids having antibacterial activity |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733982 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity |
| 05/11/2004 | US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 05/11/2004 | US6733797 Neuroceutical for improving memory and cognitive abilities |
| 05/11/2004 | US6733794 Topical composition for antiseptic and analgesic purposes |
| 05/11/2004 | US6733793 Oral composition with insulin-like activities and methods of use |
| 05/11/2004 | US6733792 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
| 05/11/2004 | US6733789 Polymeric coating with a ph-dependent dissolution delay with sustained release for nighttime administration |
| 05/11/2004 | US6733785 Moisture-sensitive preparation of percutaneous absorption type |
| 05/11/2004 | US6733783 Controlled release hydrocodone formulations |
| 05/11/2004 | US6733782 Core tablet for controlled release of gliclazide after oral administration |
| 05/11/2004 | US6733780 Direct compression polymer tablet core |
| 05/11/2004 | US6733779 Method of treating benign prostatic hyperplasia and other benign prostate conditions |
| 05/11/2004 | US6733778 Ph stabilizing agent lysine or arginine in pellet core, which is directly enteric coated without a separating layer |
| 05/11/2004 | US6733775 Plastic films, especially for use in a dermal or transdermal therapeutic system |
| 05/11/2004 | US6733769 Edible viscosity lowering polysaccharide; a maltodextrin-glucomannan complex |
| 05/11/2004 | US6733764 Administering an effective amount of urushiol to a cancer patient for the enhancement of immune system |
| 05/11/2004 | US6733744 Indole compounds as minimally invasive physiological function monitoring agents |
| 05/11/2004 | US6732573 Single riser/single capillary blood viscometer using mass detection or column height detection |
| 05/11/2004 | CA2352597C Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 05/11/2004 | CA2312898C Long acting injectable formulations containing hydrogenated castor oil |
| 05/11/2004 | CA2279428C Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 05/11/2004 | CA2225960C Pharmaceutical compositions |
| 05/11/2004 | CA2188785C Melt granulated sucralfate preparations and a process for their production |
| 05/11/2004 | CA2184411C Process for preparing polymorphs b and c of 1-[2,4-dichloro-.beta.-[(7-chlorobenzo[b]thien-3-yl)methoxy]phenethyl]imidazole mononitrate |
| 05/11/2004 | CA2156481C 5-ht2 receptor antagonist compositions useful in treating venous conditions |
| 05/11/2004 | CA2120367C Compositions and use of pharmaceutical compositions in the treatment of symptoms of disorders related to chronic inflammatory diseases and etiologically related symptomology |
| 05/11/2004 | CA2104594C Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 05/11/2004 | CA2101779C Defoaming composition |
| 05/11/2004 | CA2099569C New a83543 compounds and process for production thereof |
| 05/11/2004 | CA2062341C Use of hydrophilic penetrating agents in dermatological compositions for the treatment of onychomycosis, and corresponding compositions |
| 05/08/2004 | WO2004064828A1 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 05/08/2004 | CA2512484A1 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 05/07/2004 | CA2413981A1 Method for providing natural therapeutic agents with high therapeutic index |
| 05/06/2004 | WO2004038006A2 Purine nucleosides |
| 05/06/2004 | WO2004038001A2 Substituted tetracycline compounds for the treatment of malaria |
| 05/06/2004 | WO2004038000A2 Methods of using substituted tetracycline compounds to modulate rna |
| 05/06/2004 | WO2004037997A2 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof |
| 05/06/2004 | WO2004037978A2 Methods of reducing the activity of and reducing the concentration of a mutant kit protein |
| 05/06/2004 | WO2004037972A2 Endogenous retrovirus up-regulated in prostate cancer |
| 05/06/2004 | WO2004037971A2 Use of heterocyclic amine-type compounds as neuroprotective agents |
| 05/06/2004 | WO2004037865A1 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 05/06/2004 | WO2004037853A2 Quinolones with anti-hiv activity |
| 05/06/2004 | WO2004037843A2 Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments |
| 05/06/2004 | WO2004037828A1 Process for producing optically active sulfoxide |
| 05/06/2004 | WO2004037823A1 Purine compounds and uses thereof as cannabinoid receptor ligands |
| 05/06/2004 | WO2004037822A1 7-phenyl pyrazolopyridine compounds |
| 05/06/2004 | WO2004037812A1 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
| 05/06/2004 | WO2004037811A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | WO2004037798A1 Nitric oxide releasing selective cyclooxygenase-2 inhibitors |